Table 1

Comparison of the total amount and phosphorylation state of the major components of the PI3-K/Akt/PTEN and CK2 by densitometric scanning

CLL (n = 44)HD (n = 8)P
PDK1-total 1.72 ± 0.6 0.25 ± 0.2 < .001 
PDK1-pS241 1.43 ± 0.3 0.13 ± 0.1 < .001 
Akt1-total 1.82 ± 0.6 1.45 ± 0.2 NS 
Akt1-pT308 1.35 ± 0.7 0.12 ± 0.09 < .01 
Akt1-pS473 1.53 ± 0.45 1.1 ± 0.56 < .05 
PTEN-total 1.72 ± 0.73 1.69 ± 0.63 NS 
PTEN-pS380 1.65 ± 0.69 0.65 ± 0.67 < .01 
PTEN-pS370 1.63 ± 0.55 0.43 ± 0.15 < .01 
PTEN-pSTS 1.43 ± 0.6 0.27 ± 0.13 < .01 
CK2-pS209 1.53 ± 0.54 0.3 ± 0.12 < .001 
CLL (n = 44)HD (n = 8)P
PDK1-total 1.72 ± 0.6 0.25 ± 0.2 < .001 
PDK1-pS241 1.43 ± 0.3 0.13 ± 0.1 < .001 
Akt1-total 1.82 ± 0.6 1.45 ± 0.2 NS 
Akt1-pT308 1.35 ± 0.7 0.12 ± 0.09 < .01 
Akt1-pS473 1.53 ± 0.45 1.1 ± 0.56 < .05 
PTEN-total 1.72 ± 0.73 1.69 ± 0.63 NS 
PTEN-pS380 1.65 ± 0.69 0.65 ± 0.67 < .01 
PTEN-pS370 1.63 ± 0.55 0.43 ± 0.15 < .01 
PTEN-pSTS 1.43 ± 0.6 0.27 ± 0.13 < .01 
CK2-pS209 1.53 ± 0.54 0.3 ± 0.12 < .001 

The expression of the total amount and phosphorylation state of PDK1, Akt1, PTEN and CK2 was measured by Western blotting, and signals were quantified by densitometric scanning and corrected to β-actin levels. Values are mean ± SD. The table corresponds to the Western blotting data shown in Figure 5 

CLL indicates chronic lymphocytic leukemia; HD, healthy donor; and NS, not significant.

or Create an Account

Close Modal
Close Modal